Tag-Archive for ◊ Smith & Nephew ◊

• Wednesday, January 29th, 2014

Negative Pressure Wound Therapy helps reduce infections and other surgical complications, according to a clinical review published by a Smith & Nephew-funded expert panel. Smith & Nephew (FTSE:SN, NYSE:SNN) touted the outcomes of a clinical study review, reporting that Negative Pressure Wound Therapy proved effective in reducing complications when applied to surgical wounds for a few […]

• Tuesday, October 08th, 2013

A federal judge orders Arthrex to halt sales of some of its suture anchor products in a patent infringement lawsuit filed by Smith & Nephew. Smith & Nephew (FTSE:SN, NYSE:SNN) claimed a win today in its long-running patent infringement battle with rival Arthrex, after a federal judge in Oregon ordered Arthrex to stop selling some of […]

• Wednesday, August 28th, 2013

Smith & Nephew and Northwest Ortho Plus come to a closed-doors agreement to settle all allegations in a $56 million trade secrets theft lawsuit. Healthcare giant Smith & Nephew (FTSE:SN, NYSE:SNN) came to terms with former staffing services provider Northwest Ortho Plus, putting to bed a year-old trade secrets dispute. The original lawsuit, which accused Northwest of damaging […]

• Monday, July 15th, 2013

A federal appeals court overturns a ruling by the U.S. Patent & Trademark Office that a bone plate patent owned by Johnson & Johnson subsidiary Synthes is valid, handing a win to orthopedics rival Smith & Nephew. A federal appeals court handed a win to Smith & Nephew (FTSE:SN, NYSE:SNN) in its patent battle with Johnson & Johnson (NYSE:JNJ) […]

• Wednesday, December 14th, 2011

Smith & Nephew (NYSE:SNN) laid off 80 employees following the merger of its Andover, Mass.-based endoscopy unit and its Memphis, Tenn.-based orthopedic reconstruction unit, according to a report in the Memphis Commercial Appeal. The British orthopedic giant announced that it would combine the two units in July, alongside the resignation of Memphis-based orthopaedic reconstruction president Joseph […]

• Monday, November 14th, 2011

The FTSE 100 medical devices manufacturer has said it will increase its research and development budget by $300m (£186m) over the next five years and plans to set aside 20pc of this for emerging markets. The investment comes as Smith & Nephew sharpens its focus on countries such as Brazil, Russia, China and India, with […]

• Tuesday, April 19th, 2011

Reminding your bones to grow…Smith & Nephew has announced a new, free service that helps patients keep on track with their physician-prescribed EXOGEN Ultrasound Bone Healing System treatment plans. Via EXOGEN CONNECTS, patients can receive reminders and tips for healthy living. Those who enroll in EXOGEN CONNECTS have on hand a personal wellness and support […]

• Monday, January 10th, 2011

Shares of Smith & Nephew surged on the London Stock Exchange on Monday, getting a boost from a report that the medical device maker had rejected a £7 billion, or $10.9 billion, takeover bid by Johnson & Johnson. On Saturday, the city editor of Sky News, Mark Kleinman, wrote on his blog that Johnson & Johnson had approached […]